Evidence map›Paper›PMID 26072493›Full record

ArticleBioinformatics (Oxford, England)2015

Phenome-driven disease genetics prediction toward drug discovery.

Yang Chen, Li Li, Guo-Qiang Zhang, Rong Xu

Open access · hybridAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Disease comorbidity-guided drug repositioning: a case study in schizophrenia.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Interrogating Patient-level Genomics and Mouse Phenomics towards Understanding Cytokines in Colorectal Cancer Metastasis.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2017
    Article
  17. Drug repositioning for prostate cancer: using a data-driven approach to gain new insights.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yang ChenDepartment of Electrical Engineering and Computer Science, Department of Epidemiology and Biostatistics and Department of Family Medicine and Community Health, Case Western Reserve University, Cleveland, OH 44106, USA.
Li LiDepartment of Electrical Engineering and Computer Science, Department of Epidemiology and Biostatistics and Department of Family Medicine and Community Health, Case Western Reserve University, Cleveland, OH 44106, USA Department of Electrical Engineering and Computer Science, Department of Epidemiology and Biostatistics and Department of Family Medicine and Community Health, Case Western Reserve University, Cleveland, OH 44106, USA.
Guo-Qiang ZhangDepartment of Electrical Engineering and Computer Science, Department of Epidemiology and Biostatistics and Department of Family Medicine and Community Health, Case Western Reserve University, Cleveland, OH 44106, USA.
Rong XuDepartment of Electrical Engineering and Computer Science, Department of Epidemiology and Biostatistics and Department of Family Medicine and Community Health, Case Western Reserve University, Cleveland, OH 44106, USA.
Case Western Reserve University · US

Funding

TRAINING IN COMPUTATIONAL GENOMIC EPIDEMIOLOGY OF CANCERR25CA094186 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI LI, LI · 2002 to 2016
$6.8M
Rapid reverse translational drug repositioningDP2HD084068 · NICHD · CASE WESTERN RESERVE UNIVERSITY · PI XU, RONG · 2014 to 2014
$2.4M
NCCDPHP CDC HHS DP2HD084068NCI NIH HHS R25 CA094186NCI NIH HHS R25 CA094186-06NICHD NIH HHS DP2 HD084068
6 · The paper itself

Abstract

motivationDiscerning genetic contributions to diseases not only enhances our understanding of disease mechanisms, but also leads to translational opportunities for drug discovery. Recent computational approaches incorporate disease phenotypic similarities to improve the prediction power of disease gene discovery. However, most current studies used only one data source of human disease phenotype. We present an innovative and generic strategy for combining multiple different data sources of human disease phenotype and predicting disease-associated genes from integrated phenotypic and genomic data.

resultsTo demonstrate our approach, we explored a new phenotype database from biomedical ontologies and constructed Disease Manifestation Network (DMN). We combined DMN with mimMiner, which was a widely used phenotype database in disease gene prediction studies. Our approach achieved significantly improved performance over a baseline method, which used only one phenotype data source. In the leave-one-out cross-validation and de novo gene prediction analysis, our approach achieved the area under the curves of 90.7% and 90.3%, which are significantly higher than 84.2% (P < e(-4)) and 81.3% (P < e(-12)) for the baseline approach. We further demonstrated that our predicted genes have the translational potential in drug discovery. We used Crohn's disease as an example and ranked the candidate drugs based on the rank of drug targets. Our gene prediction approach prioritized druggable genes that are likely to be associated with Crohn's disease pathogenesis, and our rank of candidate drugs successfully prioritized the Food and Drug Administration-approved drugs for Crohn's disease. We also found literature evidence to support a number of drugs among the top 200 candidates. In summary, we demonstrated that a novel strategy combining unique disease phenotype data with system approaches can lead to rapid drug discovery. AVAILABILITY AND IMPLEMENTATION: nlp. CASE: edu/public/data/DMN

Indexed as

PhenotypeCrohn DiseaseDatabases, GeneticDiseaseDrug DiscoveryGenesGenomicsHumansProtein Interaction Mapping

Identifiers

PMID26072493
PMCPMC4542779
OpenAlexW2149023901

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.